NPM1-Mutation

Ziftomenib: A Promising New Treatment for NPM1-Mutated Acute Myeloid Leukemia

Kura Oncology’s recent presentation at the European Hematology Association (EHA) 2023 conference highlighted the impressive clinical potential of ziftomenib in ...